Human Milk Sample Composition in Israeli Mothers and Correlation With Their Diet
Overview
The study will collect human milk from 100 mother of term infants 2-3m after delivery and from 50 mothers of preterm infants 14 and 30 days after delivery. Sample content will be analysed and statistical analysis will look at correlation between demographics, dietary habits and milk composition.
Full Title of Study: “Human Milk Sample Collection From Israeli Mothers and Its Analysis and Correlation Between Composition, Demographics and Diet”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: August 2017
Arms, Groups and Cohorts
- Mothers for term infants
- Lactating mothers
- Mothers for preterm infants
- Lactating mothers
Clinical Trial Outcome Measures
Primary Measures
- Analysis of natural lipids in human breast milk of Israeli’s mothers
- Time Frame: 30-60 days after delivery
- exploratory study
Secondary Measures
- Maternal diet survey
- Time Frame: 30-60 days after delivery
- exsploratory study
Participating in This Clinical Trial
Inclusion Criteria
Generally healthy mothers who give birth to a healthy term infant (37-42 weeks) Mothers who intend to breastfeed the infant at least 80% of the daily feeding Mothers who can comply with the study requirements Mothers who sign the informed consent form in writing and can read and write Hebrew. Exclusion Criteria:
- Participation in any other studies involving investigational or marketed products Is consuming alcoholic drinks and is a drug abuser. Is suffering from chronic disease Presence of psychosis and severe post-partum depression. Mothers who have given birth to twins or multiples Mothers who received chemotherapy or isotopes during pregnancy investigator's uncertainty about the willingness or ability of the mothers to understand and comply with the protocol requirements. Infants: Any congenital abnormality, chromosomal disorder or severe disease which could interfere with the study conduct and assessment.
Gender Eligibility: Female
Minimum Age: 15 Years
Maximum Age: 55 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Enzymotec
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Yael Lifshitz, PhD, Study Director, Employee
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.